Home › Immunoglobulin Light-chain Amyloidosis
Pag-aaral pangklinika para sa Immunoglobulin Light-chain Amyloidosis na nagre-recruit sa U.S.
16 pag-aaral para sa Immunoglobulin Light-chain Amyloidosis ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Boston, MA8 pag-aaral
- Rochester, MN5 pag-aaral
- Durham, NC4 pag-aaral
- New York City, NY4 pag-aaral
- New Haven, CT3 pag-aaral
- Columbus, OH3 pag-aaral
- Cleveland, OH3 pag-aaral
- Nashville, TN3 pag-aaral
- Salt Lake City, UT3 pag-aaral
Ayos sa estado
- Arizona3 pag-aaral
- California4 pag-aaral
- Connecticut3 pag-aaral
- Florida3 pag-aaral
- Massachusetts8 pag-aaral
- Minnesota5 pag-aaral
- New York4 pag-aaral
- North Carolina4 pag-aaral
- Ohio5 pag-aaral
- Tennessee5 pag-aaral
- Texas3 pag-aaral
- Utah3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07224672Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT01137643Screening for AL Amyloidosis in Smoldering Multiple Myeloma
Nagre-recruitObservasyonal na pag-aaral
Edad 40 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06365060Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05898646SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07850284A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06768489Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT06569147Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05145816A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT05951816Teclistamab-Daratumumab in AL Amyloidosis
Nagre-recruitPhase 2
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT07110844A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT07081646Registry of Older Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 65 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT01137825Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT06022939Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 23, 2026 · NCT01408225Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 1, 2025 · NCT00898235Molecular Imaging of Primary Amyloid Cardiomyopathy
Nagre-recruit
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Nob 14, 2025 · NCT02641145Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.